SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000895345-17-000063
Filing Date
2017-02-13
Accepted
2017-02-13 16:15:48
Documents
3
Group Members
PERRIGO CORP LTD.PERRIGO HOLDINGS LTD.PERRIGO PHARMA INTERNATIONAL DACPERRIGO SCIENCE ONE LTD.

Document Format Files

Seq Description Document Type Size
1 mh13g-proteostasis_perrigo.htm SC 13G 136585
2 mh13g-exh99_1.htm EX-99.1 1325
3 mh13g-exh99_2.htm EX-99.2 15594
  Complete submission text file 0000895345-17-000063.txt   155366
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Subject) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-89403 | Film No.: 17599313
SIC: 2834 Pharmaceutical Preparations

Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN L2 L2 2 269-673-8451
PERRIGO Co plc (Filed by) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0627
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations